Live Attenuated New Castle Disease Virus Vaccine
AVIVAX-FTM is a freeze-dried live attenuated New Castle disease viral vaccine prepared from the ‘F’ strain of the virus. The diluent is used to re-hydrate the freeze-dried component.
New Castle disease is caused by specified viruses of the avian paramyxovirus type 1(APMV-1) serotype of the genus Rubulavirus belonging to the family Paramyxoviridae. There are nine types of avian paramyxoviruses designated APMV-1 to APMV-9. New castle disease virus has been designated APMV-1. Since its recognition in 1926 the disease has been regarded as being endemic in many countries. Prophylactic vaccination is practised in all but a few of the countries that produce poultry on a commercial scale.
AVIVAX-FTM is a lentogenic vaccine prepared from the ‘F’ strain after subjection to selection and cloning. Being a live vaccine AVIVAX-FTM induces a stronger immune response against New castle disease compared to the inactivated vaccines.
For the active immunization of healthy poultry against New castle disease.
DOSAGE AND ADMINISTRATION
Reconstitute each vial with the corresponding sterile diluent. Keep the reconstituted vaccine cool and protected from sunlight. Take reasonable aseptic precautions in reconstituting and withdrawing the vaccine. Administer two drops, one into each nostril using a suitable pipette to birds of over 14 days old. Primary inoculation should be followed by a second one six weeks later. CONTRA-INDICATIONS, WARNINGS for Veterinary use only. Do not vaccinate un-healthy birds. Do not use if seal is broken or package is damaged.
Store at -20°C. (Freezer). Under these conditions, the shelf life is 2 years. If stored at between +2°C and +8°C (refrigerator) the shelf life is one month. Once the vaccine has been reconstituted, it must be used immediately and any remaining quantity discarded.
100-dose vials packed together with the corresponding diluent.